Gold nanoparticles exhibit intense and narrow optical extinction bands due to the phenomenon of plasmon resonance making them useful as contrast agents for light-based imaging techniques. Localized heating results from the absorbed light energy, which shows potential for these particles in photothermal therapy as well. The bioconjugation of gold nanoparticles to appropriate antibodies targeted to tumors in vivo, could make highly selective detection and therapy of tumors possible. We have synthesised gold nanorods based on seed mediated protocols using two methods. The first method is based on using a mono-surfactant silver assisted method which produces gold nanorods having plasmon peaks between 670-850 nm within the "optical imaging and therapeutic window". These nanorods have aspect ratios between 2.3 -3.7. A second method is a silver assisted bi-surfactant method which produce nanorods with peaks in the range of 850-1100 nm having aspect ratios between 5 -11. Typical concentrations of these particles in aqueous dispersions are in the range of 1x10 10 -1x10 11 particles per mL. We have bioconjugated these gold nanorods with anti-HER2/neu mouse monoclonal antibodies (MAb). Since the as-prepared CTAB-stabilized nanorods were found to be toxic to SKBR3 cells, we decided to coat the gold nanorods with polyethylene glycol (PEG). Characterization and size estimation of the nanoparticles were performed using electron microscopies, optical spectroscopy and confocal microscopy. We present these results and implications for use of these nanoparticles for in vivo biomedical applications.
INTRODUCTION
The strong surface plasmon resonances of gold nanoparticles at optical frequencies make them excellent scatterers and absorbers of light [1] . The notable use of gold nanoparticles has been as contrast agents in cellular and biomedical imaging [2, 3] . The purpose of these contrast agents is to improve the sensitivity and specificity of the measuring modality by site-specifically labeling tissues or cells of interest. Rod-shaped gold nanoparticles have unique optical properties [4] . They show two surface plasmon bands due to the electronic oscillation of free conducting electrons in an electromagnetic field. The transverse and the longitudinal plasmon bands are due to this effect of resonance on the nanorod surface. The transverse plasmon band occurs at ~520 nm in the green part of the spectrum and the longitudinal plasmon band in the near-infrared region (NIR) part of the spectrum. The location of the longitudinal plasmon peak can be tuned in the NIR region by changing the aspect ratio (ratio of length to width) of the particles.
For use in light-based imaging or therapy in tissues, contrast agents should have strong optical absorption and/or scattering in the NIR part of the spectrum where penetration of light is high. In the wavelength regime between 600 nm and 1100 nm, absorption and scattering losses are minimal permitting high light penetration. This is the so-called "optical imaging window" which is exploited for deep imaging in tissue. Further, to use gold nanorods for the purpose of contrast enhancement in imaging, the appropriate aspect ratios should be synthesized that place the longitudinal peak in this range. Further to impart specificity to the disease-state such as cancer, that is being imaged or treated targeted delivery is a key parameter [5] . This can be achieved by conjugating the particles with proteins such as antibodies or peptides having affinity for disease markers. For in vivo use we require the nanoparticles and their chemical constituents to be biocompatible which may require modification of their surfaces.
Here, in this paper we report the seed mediated synthesis of gold nanorods using two methods (silver assisted monosurfactant and bi-surfactant methods) based on protocols of Nikoobakht et al [6] . In the bi-surfactant method, we have improved the protocol by changing the concentrations of the chemical components during the synthesis. In the case of mono-surfactant gold nanorods, we have found that the chemical components used for synthesis were toxic to cells. Therefore, to make gold nanorods biocompatible, we have coated gold nanorods with polyethylene glycol (PEG) and studied cytotoxicity in vitro on SKBR3 cells. The gold nanoparticles were also characterized using optical spectroscopy, electron microscopies and confocal microscopy.
EXPERIMENTAL METHODS

Materials
Tetrachloroauric acid (HAuCl 4 .3H 2 O) was purchased from Acros Organics (Belgium), hexadecyltrimethylammonium bromide (CTAB; > 99 %) and mPEG-SH 5000 from Fluka (The Netherlands) benzyldimethylhexadecylammonium chloride (BDAC, 99%) from Sigma (The Netherlands), sodium borohydride (NaBH 4 , 99%) and ascorbic acid (99%) from Aldrich (The Netherlands), silver nitrate (AgNO 3 , 99.8%) from Merck (Germany), RPMI 1640 from Invitrogen (The Netherlands). All reagents were used as received. Prior to use, all glassware was cleaned with hydrofluoric acid (HF), further with aqua regia (HCl/HNO 3 ) and rinsed twice with deionised water.
Synthesis of 3.5 nm diameter gold spheres
The synthesis was done using protocols of Nikoobakht et al [6] with slight modifications. A solution of CTAB (5 mL; 0.2 M) was sonicated for 20 minutes at 40˚C in a water bath. A solution of HAuCl 4 .3H 2 O (5 mL; 0.0005 M) was added with continuous stirring under inert conditions (nitrogen environment). Then, an ice-cold aqueous solution of NaBH 4 (0.6 ml; 0.01 M) was added at once with vigorous stirring for 1 minute. This seed solution (CTAB-capped) is further used during growth stage of nanorods.
Gold nanorods having optical absorption wavelengths from 670-850 nm using mono-surfactant method
Five identical flasks containing 5 mL of a growth solution that consists of CTAB (0.2 M) and HAuCl 4 .3H 2 O (0.001 M) were prepared. AgNO 3 (0.006 M) was added in various flasks in an amount that was chosen so as to yield desired aspect ratios for the resulting nanorods. Following this, the mild reducing agent ascorbic acid (0.1 M) was added to each solution to give colourless solutions. Finally, 14 µL of a preformed CTAB-capped seed solution was added to each conical flask and mixtures were gently mixed. After 3 hours at 24˚C, the nanorod suspension turned into a dark blue solution with a brownish opalescence. These solutions were concentrated by centrifugation which also enabled to remove the excess of unbound CTAB, and stored at 4˚C.
Gold nanorods having optical absorption wavelengths above 850 nm using bi-surfactant method
The gold nanorods having absorption wavelengths higher than 850 nm were prepared using the bi-surfactant method, in two steps as follows:
Step 1.
The gold nanorods were synthesized using BDAC/CTAB introduced in a ratio of 2.7. The yield of nanorods is different for different ratios depending on the amount of CTAB used. 0.25 M BDAC was sonicated for 20 minutes and to this solution, 100 mg of CTAB is added and further sonicated at 40˚C for 20 minutes. 250 µL of AgNO 3 (0.006 M) was added and gently stirred. 5 mL of HAuCl 4 .3H 2 O (0.0005 M) is then added to the solution. 70 µL of ascorbic acid (0.1 M) is added and the solution turned colorless because of partial reduction of gold salt. Finally, CTAB-capped seed solution of 14 µL was added. At this stage, the nanorods have longitudinal plasmon peak in between 850-880 nm.
Step 2.
The growth solution consists of (0.2/0.25) of CTAB/BDAC, 0.001 M HAuCl 4 .3H 2 O, 0.006 M AgNO 3 and 0.1 M of ascorbic acid. To shift the longitudinal plasmon peak of the resulting nanorods towards the red, 2 mL of the growth solution was added every 35 minutes to the above formed nanorods (850-880 nm). This time was chosen because the red shifting of longitudinal plasmon peak was higher. This was not the case with time periods less than 35 minutes. With each addition of growth solution a red-shift of 15-20 nm in the location of longitudinal plasmon peak occurs. After a certain point, further addition of growth solution has no more effect on the shift due to depletion of gold ions within the solution.
Characterization of gold nanoparticles
Electron microscopy of the NPs was performed using a Zeiss-1550 high-resolution Scanning Electron Microscope (HRSEM). Particle sizes were estimated using NI Vision Module (LABVIEW) on the digital HR-SEM images with at least 250 particles considered in each case. Extinction spectra's of nanoparticles (and bioconjugated NPs) were measured using the Shimadzu PC3101-Optical spectrophotometer.
PEGylation of gold nanorods
A stock solution of PEG-SH at 5 mM was prepared using DI water. The nanorod solution (concentration of 2.7x10 10 particles per mL) was washed (20 min at 7000 g) and the resulting pellet re-suspended in a PEG-SH solution at a final concentration of 2.5 mM. The sample was vigorously vortexed for 30 sec and let for reaction at room temperature for 1 hour. After one hour, the sample was washed again twice with fresh phosphate buffer saline (1x PBS) to remove the excess of unbound PEG-SH and placed in PBS.
Cell culture and cell-bioconjugate incubation
The Her2/neu positive mammary adenocarcinoma (SKBR3) cell line was used as a HER81-positive cell line. The cells were cultured in RPMI 1640 medium supplemented with glutamine, 10 % FBS (Fetal Bovine Serum) with antibiotics. Cells were maintained in an incubator at 37˚C and 5 % CO 2 . The medium was changed every 3 days to keep confluent cells. Before the experiment, cells were harvested using a trypsin solution (1%) and seeded onto 12 mm glass cover slips placed in a 6-well tissue culture plate, and allowed to grow for 2 days at 37ºC, 5% CO 2 to reach 80% confluence. Cells were then washed with fresh PBS and fixated in 4% paraformaldehyde (PFA) for 15 minutes at room temperature. After fixation, immuno-staining was performed on cells. The cells were incubated with 100 µL of conjugated gold nanorods at a concentration of 9.7x10 10 particles per mL for 2 hours. Later, silver staining (consists of initiator solution and enhancer solution where the silver ions nucleate around gold particle and deposits as silver metal which can reflect light and the signal is amplified) was done on cell-gold nanorod antibody bioconjugate and visualized under confocal microscopy.
Cytotoxicities of gold nanorods
The cytotoxicity of bared CTAB-stabilized nanorods was compared to that of PEGylated nanorods. For that purpose, SKBR3 cells were plated on cover slips placed in a 24-well plate one day before the experiment and kept in an incubator (37ºC, 5% CO 2 ) to reach an 80% confluency. The nanorods solution were washed once in PBS and added to the culture medium of cells to give a final concentration of 8.7x10
9 particles per mL (14.4 pM). After 24 hours incubation of the nanorods with the cells, the viability of the cells was assessed and the cells were washed and placed in a PBS solution containing propidium iodide (PI) at a final concentration of 5 µg/mL. After a few minutes incubation, cells were imaged using microscopy techniques and the amount of dead cells (i.e. red-stained nuclei) was qualitatively measured. Excitation was done with a 543 nm and emitted light collected with a LP 560 nm filter block.
RESULTS
We investigated two methods for synthesizing gold nanorods, a mono-surfactant method or a bi-surfactant method. Both methods yield particles with different geometrical characteristics (aspect ratio) and consequently, different optical properties.
Silver-assisted mono-surfactant gold nanorods
The CTAB-capped seeds were introduced into the growth solution which leads to the formation of gold nanorods. By varying the amount of silver nitrate added in solution, the properties of the resulting nanorods can be tuned. VveIength (nm)) 600 900 Figure 1 shows the optical extinction spectrum of gold nanorods synthesized using the silver-assisted mono-surfactant method. The peak at 764.5 nm can be attributed to the longitudinal plasmon resonance whereas the peak in the vicinity of 516.5 nm corresponds to the transverse plasmon resonance. The presence of the transverse and longitudinal plasmon peaks is due to the conduction of electrons along the short axis and the long axis of the nanorod, respectively. The extinction coefficient value of the longitudinal plasmon peak is much higher than the transverse plasmon peak which indicates the formation of a high yield of gold nanorods. The concentration of the synthesized nanorods was 7.3x10 10 particles per mL. To estimate the sizes of the nanorods, HR-SEM imaging was carried out (shown in Figure 2 ). The high resolution scanning electron microscope image showed high yield of gold nanorods with very low amount of large nanospheres.
The number or particles were measured and a distribution histogram was plotted to determine the mean average aspect ratio of the obtained nanorods. Figure 3 represents the histogram illustrating the distribution of the gold nanorods obtained when using (100 µL) of silver nitrate; they have a mean aspect ratio of 2.9 with high monodispersity and nearly 29 % of the particles have this aspect ratio value. The mean aspect ratio is determined by measuring the mean average length (45.1 nm) and the mean average width (15.8 nm). 250 particles were measured for estimating the sizes of the particles. Finally we varied the amount of silver nitrate added to the reaction mixture to see to which extent the characteristics and optical properties of the nanorods could be changed. Figure 4 shows the normalized spectra of the gold nanorods obtained using 50, 100, 150, 200 and 250 µL of a 0.006 M silver nitrate solution. All the batches of nanorods exhibit the same peak at 516 nm, corresponding to their transverse plasmon resonance as well as the signature peak of gold nanospheres. However, the peak in the NIR range that corresponds to the longitudinal plasmon resonance is shifted towards higher wavelengths values when the amount of silver nitrate added into the growth solution is increased as demonstrated by earlier work as well [6] . It is seen that red-shifting of longitudinal plasmon peak is limited to around 850 nm; further addition of silver nitrate shows blue-shifting of the peak.
Bi-surfactant synthesized gold nanorods
This method using CTAB and BDAC as surfactants yields nanorods presenting a higher longitudinal plasmon resonance, above 850 nm, i.e. above the highest value possibly reachable with the mono-surfactant method. Indeed, the bi-surfactant method presents more flexibility in the composition of the reaction mixture, as the ratio of the two surfactants can also be varied.
We consequently prepared gold nanorods using BDAC and CTAB as surfactants, these being introduced with a 2.7 ratio. Figure 5 shows the extinction spectrum of gold nanorods obtained using the two-surfactant (BDAC/CTAB) method, BDAC and CTAB being introduced with a 2.7 ratio. The two peaks at 525 nm and 1036 nm represents the transverse and longitudinal plasmon resonance peaks, respectively. The comparable amplitudes of the two plasmon peaks shows that a high yield of unwanted nanospheres are also produced. The concentration of gold nanorods was determined to be of 5x10 10 particles per mL. The spectrum also presents a small shoulder at 650 nm which can be due to the aggregation of large spheres or to the formation of other anisotropic nanostructures such as nanocubes. . HR-SEM image of gold nanorods synthesized using the bi-surfactant method using a 2.7 ratio of BDAC and CTAB.
The resulting nanorods were also characterized by high-resolution SEM technique (See figure 6) . The picture reveals a large amount of nanospheres besides the desired nanorods. This appears to be a drawback of the bi-surfactant method as implemented here compared to the mono-surfactant one. As before the average dimensions of the nanorods were determined and their aspect ratios plotted as a histogram. Figure  7 shows the histogram of gold nanorods which have a mean average aspect ratio of 10.9 (mean average length of 105.5 nm; mean average width of 9.9 nm). Nearly 20% of the gold nanorods have a mean aspect ratio of 10.9. We also see in the histogram that 16% of the nanorods have a mean aspect ratio of 10.9. Compared to the nanorods obtained with he mono-surfactant method, we can say that the aspect ratio here is much higher (10.9 vs. 2.9) but presents a higher dispersity as well (2.4 vs. 0.6).
Bioconjugation of HER81 MAb to mono-surfactant gold nanorods
For tumor imaging and killing purposes, nanorods must be specifically immobilized on tumor cells. For that purpose they are functionalized with an antibody that binds in a specific way to tumor cells by recognition of the HER2 receptor present on their surface, and later incubated with cells. A preliminary experiment about the recognition and binding of nanorods on cancer cells (SKBR3) was done on fixed cells. Cells were incubated (2 hours) with Mab-functionalized gold nanorods and then washed with phosphate buffer saline (PBS). Binding of the conjugated gold nanorods to cells was assessed by silver-based immuno-staining of the cells and imaging by confocal microscopy techniques. Silver staining was done to enable the visualization of gold nanorods. HER2 receptors that are expressed at the cell membrane are now coupled to functionalized nanorods. The high intensity of the signal at the cell membrane indicates successful conjugation and retention of functionality of the antibody after conjugation. We also did a negative-control tests using CHO (Chinese Hamster Ovary) cell line which are negative for targeted receptor and show no reflection from gold nanorod conjugated antibody (data not shown).
Cytotoxicity studies of gold nanorods
The toxicity of nanoparticles for cells is a major concern. The final goal is to use them in vivo for tumor imaging and killing, so that their bio-compatibility and bio-delivery must be ensured. The cytotoxicity of gold nanoparticles is welldocumented in the literature and should be reduced by adding a capping layer on the particles. We decided to use PEG as a capping layer; this should enable to reduce the toxicity of the particles and simultaneously facilitate their dissolution in aqueous solutions.
PEGylation of the nanorods was carried out as described in the experimental part. Thereafter the toxicity of CTABstabilized was assessed and compared to that of PEGylated nanorods. We used SKBR3 cells as before, and we did three types of experiments; either control experiments without any particles, experiments either with CTAB-stabilized nanorods or with PEGylated nanorods. After 24 hours incubation of the cells with or without nanoparticles, cell viability was checked using a nuclear staining (PI or propidium iodide). When cells die, their membrane becomes permeable so that they take up PI and their nucleus becomes stained in red. Cells were imaged using confocal microscopy techniques. 
DISCUSSION
The mono-surfactant method with the addition of silver ions in growth solution and use of preformed surfactant (CTAB) seed produced high yield of monodisperse gold nanorods as seen in Figure 2 . Further, in this protocol varying the silver content provided fine tunability of aspect ratios and longitudinal plasmon peaks. However, the mechanism of gold nanorod formation is not completely understood and this has been the topic of several studies. Recently, Murphy et al [7] proposed that the silver-assisted seed mediated protocol involves the reduction of silver by ascorbic acid by the phenomenon of underpotential deposition (UPD). This was based on earlier work by Liu and Guyot-Sionnest [8] who proposed deposition of silver monolayers on gold surfaces by ascorbic acid at a potential less than the standard reduction potential. The deposition is faster on the sidewalls bearing Au {110} faces compared to the Au {100} end faces. The bromide ions from CTAB combine with silver to form Ag-Br on the sidewalls of nanorods and thus inhibit the reduction of gold at the side faces compared with reduction at the end faces. This reduces the growth along the width of nanorod while the ends elongate causing increase in aspect ratio (length/width) [9] . Ultimately, passivation of the end walls occurs as well albeit at a lower rate by silver deposition and possible CTAB binding, limiting the length achievable using the single surfactant protocol.
To obtain nanorods with higher aspect ratios with plasmon peaks higher than 850 nm the bi-surfactant method [6] is applied. A mixture of two surfactants is used, with BDAC the dominant component compared with CTAB. As above, silver and CTAB driven passivation of the side walls occurs due to the relative higher affinity for binding with the sides compared with the end faces. UPD of silver at the tips does take place relatively slowly, and the deficiency of available CTAB to bind to the silver at the tips suggests possible BDAC binding to the tips via weaker Ag-Cl bonds [6] . The passivation of the ends does not proceed as efficiently as the side walls allowing the rods to grow longer than in a pure CTAB or CTAB dominated situation. This synthesis protocol was followed, but yielded disappointing results with nanorods not longer than in the single surfactant method. It was then decided to modify the protocol by increasing BDAC concentration and reducing the CTAB concentrations further. The rationale was to create relatively higher deficiency of CTAB and thereby to further lower Ag-Br passivation of the end faces. The first results as reported here are promising as shown in Figs. 5 and 6, though the yield of nanorods versus nanospheres requires optimization.
The non-covalent conjugation of proteins to colloidal gold is usually due to a combination of electrostatic and hydrophobic interactions. Citrate capped gold nanoparticles are negatively charged due to a layer of negative citrate ions.
Positively charged amino groups of the antibody will be attracted to the gold surface, and when the protein comes close enough for binding, the hydrophobic pockets of the protein will make contact and bind with the gold [10] . A general guideline to optimize the bioconjugation is that the pH of the antibody and the gold nanoparticles must be maintained at or slightly above the isoelectric point of the antibody. In the case of gold nanorods, it is likely that at the pH at which the antibody is maintained, the Fc fragment of the antibody that is rich in positively charged amino side chains such as lysine will bind to the negatively charged chloride ion layer on the exposed end faces of the rods.
CTAB is toxic and has been implicated in cell death when CTAB-capped gold nanospheres are incubated with cells [11] . It was demonstrated that removal of excess unbound CTAB by centrifugation reduced the toxicity of the nanospheres [11] . However, our cell viability studies on SKBR3 cells incubated with centrifuged CTAB capped gold nanorods indicate toxicity. It is not clear why these particles are detrimental to cells compared with the CTAB-nanospheres. In any case, when the nanorods are PEGylated a significant reduction in cell death is observed. It is likely that PEG displaces the CTAB bilayer from the gold surface due to the strong affinity that sulphur of the PEG-thiol has for gold [5, 12] . In such a case, reduced cytotoxicity is expected due to the non-toxic PEG coating. Colloid stability continues to be maintained even though CTAB removal occurs due to the presence of the PEG layer. However, further studies such as Raman spectroscopy and Zeta-potential measurements are required to validate the displacement of CTAB bilayer after PEG modification of gold nanorods.
CONCLUSIONS
We have synthesized gold nanorods with optical extinction peaks in the region from 675 -1000 nm making these eminently suited for scattering and absorption contrast enhancements in optical imaging. We have performed bioconjugation of mono-surfactant gold nanorods with HER81 antibodies which have affinities for the HER2/neu receptors expressed by SKBR3 breast carcinoma cells. We also studied the cytotoxicity of gold nanorods that revealed that as-prepared CTAB-capped gold nanorods are toxic to SKBR3 cells. The PEG-modified gold nanorods appear not toxic to cells and therefore have potential for in vivo biomedical applications. Further study needs to be done to check the cellular uptake of gold nanorods and to quantify the number of PEG molecules binding to the surface of gold nanorod.
